Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Skin Neoplasms × Genome × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Nevus 1 Melanoma 1 Dysplastic Nevus Syndrome 1

Interventions

pembrolizumab 8 Nivolumab 6 Ipilimumab 6 cemiplimab 4 aldesleukin 3 Interleukin-2 3 Blood Specimen Collection 3 lifileucel 2 fludarabine 2 Specimen Handling 2 Cyclophosphamide 2 Biopsy 2 trametinib 1 spartalizumab 1 pertuzumab 1 fludarabine phosphate 1 dabrafenib 1 brodalumab 1 atezolizumab 1 Trastuzumab 1 Tissue Banks 1 Standard of Care 1 Second Harmonic Generation Microscopy 1 Resistance Training 1 Red Light 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Propranolol 1 Pantothenic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05446155 2024-01-23

BioMEL

Region Skane

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡